Mianserin.
D000818:Animals; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000150:complications; D002490:Central Nervous System / Q000187:drug effects; D003866:Depressive Disorder / Q000188:drug therapy*; D003975:Diazepam / Q000627:therapeutic use; D003984:Dibenzazepines / Q000627:therapeutic use*; D004347:Drug Interactions; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007700:Kinetics; D008803:Mianserin / Q000009:adverse effects / Q000378:metabolism / Q000506:poisoning / Q000627:therapeutic use*; D010276:Parasympatholytics; D010919:Placebos
D000929:Antidepressive Agents, Tricyclic; D003984:Dibenzazepines; D010276:Parasympatholytics; D010919:Placebos; D008803:Mianserin; D003975:Diazepam